Artículo
Cross-linked hyaluronan films loaded with acetazolamide-cyclodextrin-triethanolamine complexes for glaucoma treatment
Calles, Javier Adrián
; Mora, Maria Julia
; Onnainty, Renée
; Tartara, Luis Ignacio
; Granero, Gladys Ester
; Longhi, Marcela Raquel
; Diebold Luque, Yolanda; Valles, Enrique Marcelo
; Palma, Santiago Daniel
Fecha de publicación:
02/2018
Editorial:
Future Medicine Ltd.
Revista:
Therapeutic Delivery
ISSN:
2041-5990
e-ISSN:
2041-6008
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
This work aimed to design and characterize cross-linked hyaluronic acid-itaconic acid films loaded with acetazolamide-hydroxypropyl β cyclodextrin-triethanolamine complexes. Materials & methods: Films were cross-linked with itaconic acid and poly(ethyleneglycol)-diglycidylether. Biopharmaceutical properties were assessed by evaluating in vitro drug release rate, biocompatibility in a human corneal epithelial cell line, bioadhesiveness with pig gastric mucin, in vivo bioadhesion and efficacy. Results: Showed good mechanical properties and oxygen permeability. Proliferation rate of corneal cells was affected by highest acetazolamide concentration. Bioadhesive interaction exhibited a water movement from pig mucin to the film; in vivo experiments showed strong bioadhesion for 8 h and hypotensive effect for almost 20 h. Conclusion: Experimental set showed promising performance and encouraged future studies to optimize formulation.
Palabras clave:
ACETAZOLAMIDE
,
CYCLODEXTRIN INCLUSION COMPLEX
,
GLAUCOMA
,
HYALURONAN
,
TOPICAL
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(UNITEFA)
Articulos de UNIDAD DE INVESTIGACION Y DESARROLLO EN TECNOLOGIA FARMACEUTICA
Articulos de UNIDAD DE INVESTIGACION Y DESARROLLO EN TECNOLOGIA FARMACEUTICA
Citación
Calles, Javier Adrián; Mora, Maria Julia; Onnainty, Renée; Tartara, Luis Ignacio; Granero, Gladys Ester; et al.; Cross-linked hyaluronan films loaded with acetazolamide-cyclodextrin-triethanolamine complexes for glaucoma treatment; Future Medicine Ltd.; Therapeutic Delivery; 9; 3; 2-2018; 205-219
Compartir
Altmétricas